Table 3.
Distribution of patients in the different prognostic models at the time of each procedure
| ALBI grade, n (%) | |
| Grade 1 | 295 (18.3) |
| Grade 2 | 1,272 (79) |
| Grade 3 | 43 (2.7) |
| pALBI grade, n (%) | |
| Grade 1 | 446 (27.7) |
| Grade 2 | 956 (59.4) |
| Grade 3 | 208 (12.9) |
| HAP class, n (%) | |
| Class A | 680 (42.2) |
| Class B | 561 (34.8) |
| Class C | 341 (21.2) |
| Class D | 28 (1.8) |
| mHAP-II class, n (%) | |
| Class A | 394 (24.5) |
| Class B | 632 (39.2) |
| Class C | 430 (26.7) |
| Class D | 154 (9.6) |
| mHAP-III | |
| Minimum value | −1.5478 |
| 1st quartile | −0.3438 |
| Median | 0.0294 |
| 3rd quartile | 0.4444 |
| Maximum value | 6.9163 |
1,610 procedures were performed in 1,058 patients. The table reports the distribution of patients at the time of each procedure. Therefore, data from the same patient may have been included >1 time. ALBI, albumin-bilirubin; pALBI, platelet-albumin-bilirubin; HAP, hepatoma arterial embolization; mHAP-II, modified hepatoma arterial embolization II; mHAP-III, modified hepatoma arterial embolization III.